Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...8/?tool=pubmed
Cannabinoids and Viral Infections (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full – 2010) http://www.freepatentsonline.com/EP2044935A1.html
The endocannabinoid system as a target for the treatment of neurodegenerative disease (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full – 2010)http://www.nature.com/npp/journal/va...p2010214a.html
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti Inflammatory Agents (full – 2010) http://etd.uthsc.edu/WORLD-ACCESS/Gu...030-Gurley.pdf
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full – 2010) http://www.biomedcentral.com/1471-2202/11/44
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full – 2010) http://jpet.aspetjournals.org/content/334/3/973.long
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice (abst – 2010)http://www.ncbi.nlm.nih.gov/pubmed/20868672
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst – 2010)http://www.unboundmedicine.com/medli..._2__receptors_
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19931394
Light Marijuana Use Appears Protective Against Diabetes (news – 2010) http://www.clinicalpsychiatrynews.co...1010&tx_ttnews[tt_news]=41212
Hemp Oil Benefits for Skin (news – 2010) http://www.livestrong.com/article/13...benefits-skin/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011)https://www.jstage.jst.go.jp/article.../34_5_774/_pdf
Gut feelings about the endocannabinoid system (full – 2011) http://onlinelibrary.wiley.com/doi/1...1.01689.x/full
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full – 2011) http://www.molecularpain.com/content...-8069-7-31.pdf
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full – 2011)http://www.fasebj.org/content/25/8/2711.long
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full – 2011) http://www.jimmunol.org/content/187/...2-845dc670f7cf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...h0163-1479.pdf
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (full – 2011) http://onlinelibrary.wiley.com/doi/1...11.01461.x/pdf
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...ihms278422.pdf
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti.../cr201160a.pdf
Resolution of inflammation by N-arachidonoylglycine (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01444.x/full
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full – 2011) https://www.google.com/patents/US788...ed=0CB4Q6AEwAA
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF– 2011) http://www.tswj.com/2011/230786/abs/
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21850403
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells (abst – 2011)http://www.unboundmedicine.com/medli...nnabinoid_CP55
940_inhibits_lipopolysaccharide_induced_cytokine_m RNA_expression_in_a_cannabinoid_receptor_independe nt_mechanism_in_rat_cerebellar_granule_cells_
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news – 2011)http://www.alphagalileo.org/ViewItem...CultureCode=en
New metabolic pathway for controlling brain inflammation (news – 2011) http://www.news-medical.net/news/201...lammation.aspx
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease (full – 2012) http/download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http/www.jneuroinflammation.com/content/9/1/79
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain (full – 2012) http/jpet.aspetjournals.org/content/338/1/114.full
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full – 2012) http/www.jneuroinflammation.com/content/9/1/10
Update on the role of cannabinoid receptors after ischemic stroke (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?toolubmed
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http/www.jneuroinflammation.com/content/9/1/79
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoid modulation of neuroinflammatory disorders (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full – 2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice (full - 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full – 2012) http/www.sciencedirect.com/science/article/pii/S0014299912000052
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full – 2012) http/www.jleukbio.org/content/91/6/911.full
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full – 2012) http/www.jneuroinflammation.com/content/9/1/135
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full – 2012) http/ajpgi.physiology.org/content/304/2/G181
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full – 2012) http/www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?t ext=fulltext
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Review article: Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3481533/
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full – 2012) http/www.sciencedirect.com/science/article/pii/S0014299912008485
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22226549
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22269477
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22420307
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22634229
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22492174
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst – 2012) http/www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22178458
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22777139
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22807196
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22877651
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22266325
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http/content.karger.com/produktedb/produkte.asp?doi=339113
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22337336
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst – 2012) http/onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
Neuroprotective agents: cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/21420365
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23253273
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22337285
Scientists find a new pharmacological target to modulate the effect of cannabinoids through their CB1 receptors (news – 2012) http/www.alphagalileo.org/ViewItem.aspx?ItemId=122183&CultureCode=en
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http/www.jneuroinflammation.com/content/10/1/20
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full– 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full – 2013) http/www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full – 2013) http/arthritis-research.com/content/15/6/R192
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http/www.jneuroinflammation.com/content/10/1/91
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full – 2013) http/www.pnas.org/content/110/43/17558.long
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full – 2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3650391/
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full – 2013) http/www.jimmunol.org/content/190/10/4929.long
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full – 2013) http/www.sciencedirect.com/science/article/pii/S0969996113001939
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis. (full – 2013) http/www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF – 2013) http/www.eurekaselect.com/107975/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF– 2013) http/www.eurekaselect.com/107977/article
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF – 2013) http/www.eurekaselect.com/107979/article
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23382309
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454360
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23518609
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23623250
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23813098
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst – 2013) http/www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2 -7ad0-42e4-a862-845dc670f7cf
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst – 2013) http/www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report (abst – 2013) http/www.eurekaselect.com/105507/article
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23850608
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23849204
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23181276
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23892791
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23891880
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23889474
Prospects for cannabinoid therapies in viral encephalitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24021420
Cannabidiol in inflammatory bowel diseases: a brief overview (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22815234
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23901038
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22850623
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23515857
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24275607
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23376684
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24308861
Endocannabinoids: a unique opportunity to develop multitarget analgesics (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23623250
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24384256
Sending multiple sclerosis up in smoke (news – 2013) http/www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php
5 Health Benefits Of Cannabichromene (CBC) (news – 2013) http/www.leafscience.com/2013/09/21/5-health-benefits-of-cannabichromene-cbc/
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news – 2013) http/thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
Marijuana's Memory Paradox (news/ forum repost – 2013) http/ehealthforum.com/health/interesting-t164409.html
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full – 2014) http://www.jbc.org/content/early/201...13.536953.long
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full – 2014) http://www.jpp.krakow.pl/journal/arc...14_article.pdf
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full – 2014) http://ajpgi.physiology.org/content/307/2/G140
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full – 2014) http://www.hindawi.com/journals/bmri/2014/971750/
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full – 2014) http://www.jci.org/articles/view/64628
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full – 2014) http://www.biomedcentral.com/1471-2474/15/275
Endocannabinoids and inflammatory response in periodontal ligament cells (full – 2014) http://www.plosone.org/article/info%...l.pone.0107407
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014) http://www.plosone.org/article/info%...l.pone.0113161
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full– 2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
The endocannabinoid system: an emerging key player in inflammation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24419242
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418364
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588827
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588819
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24641282
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24854329
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014) http://www.freedomwares.ca/p80cannab...sure-overload/
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014) http://onlinelibrary.wiley.com/doi/1...23452/abstract
Increased oxidative stress enhances endocannabinoid tone (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25079058
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25260980
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25273317
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25305179
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25378491
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25416141
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Neuroinflammation as a possible link between cannabinoids and addiction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25469884
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst – 2014) http://www.drugandalcoholdependence..../abstract?cc=y
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators (abst – 2014) http://www.cell.com/trends/pharmacol...2814%2900035-2
Enhanced microglial activity in FAAH-/- animals (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25534441
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25210802
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (abst – 2014) http://jpet.aspetjournals.org/conten...1-905bea766ce9
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014) http://www.sciencedaily.com/releases...0107092825.htm
Study uncovers marijuana's potential to treat autoimmune diseases (news – 2014) http://www.news-medical.net/news/201...-diseases.aspx
Synthetic cannabinoid molecule created for osteoarthritis (news – 2014) http://www.news-medical.net/news/201...arthritis.aspx
Pot Smokers Show Less Inflammation (news – 2014) http://news.yahoo.com/pot-smokers-sh...150518763.html
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015) http://www.jneuroinflammation.com/co...014-0216-1.pdf
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full – 2015) http://www.hindawi.com/journals/mi/2015/362126/
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015) http://onlinelibrary.wiley.com/doi/1...lia.22742/full
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Cannabinoids and Viral Infections (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full – 2010) http://www.freepatentsonline.com/EP2044935A1.html
The endocannabinoid system as a target for the treatment of neurodegenerative disease (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full – 2010)http://www.nature.com/npp/journal/va...p2010214a.html
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti Inflammatory Agents (full – 2010) http://etd.uthsc.edu/WORLD-ACCESS/Gu...030-Gurley.pdf
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full – 2010) http://www.biomedcentral.com/1471-2202/11/44
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full – 2010) http://jpet.aspetjournals.org/content/334/3/973.long
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice (abst – 2010)http://www.ncbi.nlm.nih.gov/pubmed/20868672
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst – 2010)http://www.unboundmedicine.com/medli..._2__receptors_
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19931394
Light Marijuana Use Appears Protective Against Diabetes (news – 2010) http://www.clinicalpsychiatrynews.co...1010&tx_ttnews[tt_news]=41212
Hemp Oil Benefits for Skin (news – 2010) http://www.livestrong.com/article/13...benefits-skin/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011)https://www.jstage.jst.go.jp/article.../34_5_774/_pdf
Gut feelings about the endocannabinoid system (full – 2011) http://onlinelibrary.wiley.com/doi/1...1.01689.x/full
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full – 2011) http://www.molecularpain.com/content...-8069-7-31.pdf
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full – 2011)http://www.fasebj.org/content/25/8/2711.long
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full – 2011) http://www.jimmunol.org/content/187/...2-845dc670f7cf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...h0163-1479.pdf
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (full – 2011) http://onlinelibrary.wiley.com/doi/1...11.01461.x/pdf
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...ihms278422.pdf
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti.../cr201160a.pdf
Resolution of inflammation by N-arachidonoylglycine (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01444.x/full
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full – 2011) https://www.google.com/patents/US788...ed=0CB4Q6AEwAA
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF– 2011) http://www.tswj.com/2011/230786/abs/
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21850403
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells (abst – 2011)http://www.unboundmedicine.com/medli...nnabinoid_CP55
940_inhibits_lipopolysaccharide_induced_cytokine_m RNA_expression_in_a_cannabinoid_receptor_independe nt_mechanism_in_rat_cerebellar_granule_cells_
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news – 2011)http://www.alphagalileo.org/ViewItem...CultureCode=en
New metabolic pathway for controlling brain inflammation (news – 2011) http://www.news-medical.net/news/201...lammation.aspx
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease (full – 2012) http/download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http/www.jneuroinflammation.com/content/9/1/79
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain (full – 2012) http/jpet.aspetjournals.org/content/338/1/114.full
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full – 2012) http/www.jneuroinflammation.com/content/9/1/10
Update on the role of cannabinoid receptors after ischemic stroke (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?toolubmed
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http/www.jneuroinflammation.com/content/9/1/79
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoid modulation of neuroinflammatory disorders (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full – 2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice (full - 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full – 2012) http/www.sciencedirect.com/science/article/pii/S0014299912000052
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full – 2012) http/www.jleukbio.org/content/91/6/911.full
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full – 2012) http/www.jneuroinflammation.com/content/9/1/135
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full – 2012) http/ajpgi.physiology.org/content/304/2/G181
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full – 2012) http/www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?t ext=fulltext
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Review article: Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3481533/
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full – 2012) http/www.sciencedirect.com/science/article/pii/S0014299912008485
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22226549
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22269477
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22420307
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22634229
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22492174
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst – 2012) http/www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22178458
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22777139
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22807196
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22877651
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22266325
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http/content.karger.com/produktedb/produkte.asp?doi=339113
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22337336
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst – 2012) http/onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
Neuroprotective agents: cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/21420365
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23253273
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22337285
Scientists find a new pharmacological target to modulate the effect of cannabinoids through their CB1 receptors (news – 2012) http/www.alphagalileo.org/ViewItem.aspx?ItemId=122183&CultureCode=en
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http/www.jneuroinflammation.com/content/10/1/20
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full– 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full – 2013) http/www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full – 2013) http/arthritis-research.com/content/15/6/R192
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http/www.jneuroinflammation.com/content/10/1/91
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full – 2013) http/www.pnas.org/content/110/43/17558.long
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full – 2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3650391/
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full – 2013) http/www.jimmunol.org/content/190/10/4929.long
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full – 2013) http/www.sciencedirect.com/science/article/pii/S0969996113001939
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis. (full – 2013) http/www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF – 2013) http/www.eurekaselect.com/107975/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF– 2013) http/www.eurekaselect.com/107977/article
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF – 2013) http/www.eurekaselect.com/107979/article
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23382309
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454360
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23518609
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23623250
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23813098
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst – 2013) http/www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2 -7ad0-42e4-a862-845dc670f7cf
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst – 2013) http/www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report (abst – 2013) http/www.eurekaselect.com/105507/article
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23850608
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23849204
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23181276
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23892791
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23891880
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23889474
Prospects for cannabinoid therapies in viral encephalitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24021420
Cannabidiol in inflammatory bowel diseases: a brief overview (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22815234
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23901038
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22850623
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23515857
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24275607
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23376684
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24308861
Endocannabinoids: a unique opportunity to develop multitarget analgesics (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23623250
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24384256
Sending multiple sclerosis up in smoke (news – 2013) http/www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php
5 Health Benefits Of Cannabichromene (CBC) (news – 2013) http/www.leafscience.com/2013/09/21/5-health-benefits-of-cannabichromene-cbc/
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news – 2013) http/thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
Marijuana's Memory Paradox (news/ forum repost – 2013) http/ehealthforum.com/health/interesting-t164409.html
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full – 2014) http://www.jbc.org/content/early/201...13.536953.long
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full – 2014) http://www.jpp.krakow.pl/journal/arc...14_article.pdf
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full – 2014) http://ajpgi.physiology.org/content/307/2/G140
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full – 2014) http://www.hindawi.com/journals/bmri/2014/971750/
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full – 2014) http://www.jci.org/articles/view/64628
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full – 2014) http://www.biomedcentral.com/1471-2474/15/275
Endocannabinoids and inflammatory response in periodontal ligament cells (full – 2014) http://www.plosone.org/article/info%...l.pone.0107407
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014) http://www.plosone.org/article/info%...l.pone.0113161
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full– 2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
The endocannabinoid system: an emerging key player in inflammation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24419242
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418364
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588827
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588819
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24641282
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24854329
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014) http://www.freedomwares.ca/p80cannab...sure-overload/
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014) http://onlinelibrary.wiley.com/doi/1...23452/abstract
Increased oxidative stress enhances endocannabinoid tone (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25079058
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25260980
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25273317
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25305179
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25378491
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25416141
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Neuroinflammation as a possible link between cannabinoids and addiction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25469884
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst – 2014) http://www.drugandalcoholdependence..../abstract?cc=y
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators (abst – 2014) http://www.cell.com/trends/pharmacol...2814%2900035-2
Enhanced microglial activity in FAAH-/- animals (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25534441
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25210802
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (abst – 2014) http://jpet.aspetjournals.org/conten...1-905bea766ce9
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014) http://www.sciencedaily.com/releases...0107092825.htm
Study uncovers marijuana's potential to treat autoimmune diseases (news – 2014) http://www.news-medical.net/news/201...-diseases.aspx
Synthetic cannabinoid molecule created for osteoarthritis (news – 2014) http://www.news-medical.net/news/201...arthritis.aspx
Pot Smokers Show Less Inflammation (news – 2014) http://news.yahoo.com/pot-smokers-sh...150518763.html
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015) http://www.jneuroinflammation.com/co...014-0216-1.pdf
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full – 2015) http://www.hindawi.com/journals/mi/2015/362126/
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015) http://onlinelibrary.wiley.com/doi/1...lia.22742/full
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726